Bonviva 150 mg is a once-monthly oral tablet containing ibandronic acid, a bisphosphonate that strengthens bones and reduces the risk of vertebral fractures in postmenopausal women with osteoporosis. /Description: Bonviva 150 mg film-coated tablets are prescribed for the treatment of osteoporosis in postmenopausal women at increased risk of fractures. The active ingredient, ibandronic acid, works by inhibiting bone resorption, leading to increased bone mineral density. Clinical studies have demonstrated its efficacy in reducing vertebral fractures; however, its effect on femoral neck fractures has not been established. The tablet is taken once a month, preferably on the same date each month, after an overnight fast and at least one hour before any food or drink (other than water) or other oral medications.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
